Glenmark Pharmaceuticals Inc., USA: Aspirin and Extended-Release Dipyridamole
Recall reason: Failed Tablet/Capsule Specification : Capsule breakage. Recalled by Glenmark Pharmaceuticals Inc., USA. Distribution: USA Nationwide. Classification (Class III — minor violation). Affected lots/NDC/dates: Lot#: 17201639, Exp 08/2022; 17201759, Exp 09/2022; 17202067, Exp 10/2022; 17210696, Exp 02/2023; 17210092, Exp 11/2022;. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report